Example: bachelor of science
Measles, Mumps, and Rubella
(1) Documented age-appropriate vaccination with live measles-, mumps-, and rubella-virus-containing vaccines, or (1) Documented doses of live measles and mumps
Information
Domain:
Source:
Link to this page:
Documents from same domain
Measles, Mumps, and Rubella - cdc.gov
www2.cdc.govAug 29, 2018 · mumps, or rubella should receive 1 dose of MMR unless they have a medical contraindication to the vaccine (e.g., pregnancy or severe immunodeficiency) • Pregnant women without evidence of immunity to rubella should receive 1 dose of MMR upon
General Recommendations on Immunization Part Two and ...
www2.cdc.govAvailable evidence does not indicate that autism is more common among children who receive MMR or thimerosal-containing vaccines ... there is no evidence that thimerosal or the MMR vaccine cause autism. Evidence does not support the theory that vaccines are causing an autism
CDC UNIFIED PROCESS PRACTICES GUIDE
www2.cdc.govCDC UNIFIED PROCESS PRACTICES GUIDE PROJECT CHARTER UP Version: 11/30/06 Page 2 of 4 A good project charter is not necessarily lengthy. The size of and time invested to develop a Project Charter should be balanced with the size and complexity of the project.
CDC UNIFIED PROCESS CHECKLIST
www2.cdc.govDocument meeting minutes . Post Meeting - Save meeting minutes to Project Notebook/documentation/file location, and make accessible to the project team . Post Meeting - Follow-up with email confirming resource responsibilities for action items and deliverables out of the meeting .
CDC UNIFIED PROCESS PRACTICES GUIDE
www2.cdc.govCDC UNIFIED PROCESS PRACTICES GUIDE CONTINGENCY PLANNING UP Version: 12/31/08 Page 1 of 5 Purpose The purpose of this document is to provide guidance on the practice of Contingency Planning and to describe the practice overview, requirements, best practices, activities, and …
General Best Practice Guidelines for Immunization, Part I
www2.cdc.govCenters for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Photographs and images included in this presentation are licensed solely for CDC/NCIRD online and presentation use.
New Hepatitis A and Hepatitis B Vaccine Recommendations
www2.cdc.govPersons with hepatitis C virus infection (new recommendation),persons with chronic liver disease (including, but not limited to, those with cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, and an alanine
Vaccine Storage and Handling and Vaccine Administration ...
www2.cdc.govJul 11, 2018 · • Reliable storage and temperature monitoring equipment • Accurate vaccine inventory management. Vaccine Storage and Handling Cold Chain (Temperature-Controlled Supply Chain) ... Check and record storage unit minimum and maximum temperatures at the start of each workday ...
Principles of Vaccination - Centers for Disease Control ...
www2.cdc.govCenters for Disease Control and Prevention ... Transfer of antibody produced by one human or animal to another Temporary protection that wanes with time Transfer of antibody through placenta –important to protect infants. Passive Immunity. Passive Immunity Video
Hepatitis B and Hepatitis B Vaccine
www2.cdc.govJan 01, 2018 · •Approved for dose 1, 2, 3 of Hep B (Do NOT use for the birth dose) ... •0, 7, 21- 30 days and a booster dose at 12 months •Each dose of Twinrix contains an adult dose of hepatitis B vaccine •A HepB series started with Twinrixcan be complete with single antigen HepB vaccine and vice versa. Combination Vaccines .
Related documents
CMS Manual System
www.cms.gov85009 Blood count; manual differential WBC count, buffy count 85013 Blood count; spun hematocrit 85014 Blood count; hematocrit (Hct) 85018 Blood count; hemoglobin (Hgb) 85032 Blood count; manual cell count (erythrocyte, leukocyte, or platelet) 85041 Blood count; red blood cell (RBC), automated 85048 Blood count; leukocyte (WBC), automated 85049 ...
PT, INR, and APTT Testing
www.doh.wa.govCentrifugation: The laboratory should review the operator’s manual for the coagulation analyzer and the reagent package insert to determine the optimal speed and time to process specimens. Platelet Poor Plasma: The CLSI defines platelet poor plasma as plasma with a platelet count of less than 10,000/μL.
Capillary Blood Collection: Best Practices
www.bd.com• Complete Blood Count (CBC), hemoglobin & hematocrit (H&H) ... to platelet clumping. Device Selection ... needlestick injuries and reuse.1 The use of manual lancets or blades without a retractable feature is a violation of OSHA regulations.3 General Site Selection
Manual on the management, maintenance and use of …
www.who.int6.3.9 Procedures for the release of platelet concentrates 53 6.3.10 Discarded blood products and their safe disposal 54 6.4 Monitoring the blood inventory 55 6.4.1 Theoretical count 55 6.4.2 Physical count 56 6.4.3 Daily blood bank report 56 6.4.4 Unused blood components 56 6.5 Model list of essential blood cold chain equipment 59
DRUG NAME: Bortezomib - BC Cancer
www.bccancer.bc.caBortezomib should be temporarily discontinued in patients with a platelet count less than 25, (NCI Grade 4 thrombocytopenia) until the platelet count returns to normal. Bortezomib can then be reinitiated at a 25% dose reduction.
Hospital Toolkit for Adult Sepsis Surveillance
www.cdc.gov5. Platelet count <100 cells/µL AND ≥ 50% decline from baseline (see below) - baseline must be ≥100 cells/µL. 6. Optional: Serum lactate ≥ 2.0 mmol/L. Note that serum lactate has become an increasingly common test to measure tissue perfusion. When serum lactate is included in the surveillance definition, the likely
Laboratory Testing Declaration
www.cdph.ca.govState of California—Health and Human Services Agency Calif. Dept. of Public Health Laboratory Field Services LABORATORY TESTING DECLARATION 850 …